CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Roche Holding Aktiengesellschaft Company Snapshot
Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other pharmaceutical manufacturers in Europe: Novartis AG (2020 sales of 46.58 billion Swiss Francs [US$50.35 billion] of which 78% was Innovative Medicines), GlaxoSmithKline plc of UNITED KINGDOM (£34.10 billion [US$46.65 billion] of which 50% was Pharmaceuticals), and Bayer AG which is based in GERMANY (41.40 billion Euros [US$48.48 billion] of which 46% was CropScience).

Sales Analysis. Sales were up sharply during the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at Roche Holding Aktiengesellschaft totalled 30.71 billion Swiss Francs. This is an increase of 117.2% from the 14.14 billion Swiss Francs in sales at the company during the second quarter of 2020. This was the biggest same quarter rise in sales at Roche Holding Aktiengesellschaft in the previous 33 quarters. During the first two quarters of 2021, sales totalled 45.64 billion Swiss Francs, which is 55.9% higher than through the first two quarters of 2020. Roche Holding Aktiengesellschaft reported sales of 58.32 billion Swiss Francs (US$63.05 billion) for the year ending December of 2020. This represents a decrease of 5.1% versus 2019, when the company's sales were 61.47 billion Swiss Francs. Contributing to the drop in overall sales was the 8.2% decline in Pharmaceuticals, from 48.52 billion Swiss Francs to 44.53 billion Swiss Francs. . However, these declines were partially offset by the increase in sales of Diagnostics (up 6.5% to 13.79 billion Swiss Francs) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Roche Holding Aktiengesellschaft
  Stock Performance Chart for Roche Holding Aktiengesellschaft
 
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): 340.40
(Figures in Swiss Francs)
1 Week -0.7%   13 Weeks -7.1%  
4 Weeks -1.3%   52 Weeks 2.9%  
 
Roche Holding Aktiengesellschaft Key Data:
  Ticker: ROG Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 58,323,000,000
(Year Ending Jan 2021).
Employees: 101,465
  Currency: Swiss Francs Market Cap: 290,790,411,381
  Fiscal Yr Ends: December Shares Outstanding: 854,260,903
  Share Type: Common Closely Held Shares: 133,668,918
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.